Institute for Cardiovascular Prevention (IPEK), Klinikum LMU Munich, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
Nat Rev Cardiol. 2020 Jun;17(6):327-340. doi: 10.1038/s41569-019-0326-7. Epub 2020 Jan 29.
Neutrophils have traditionally been viewed as bystanders or biomarkers of cardiovascular disease. However, studies in the past decade have demonstrated the important functions of neutrophils during cardiovascular inflammation and repair. In this Review, we discuss the influence of traditional and novel cardiovascular risk factors on neutrophil production and function. We then appraise the current knowledge of the contribution of neutrophils to the different stages of atherosclerosis, including atherogenesis, plaque destabilization and plaque erosion. In the context of cardiovascular complications of atherosclerosis, we highlight the dichotomous role of neutrophils in pathogenic and repair processes in stroke, heart failure, myocardial infarction and neointima formation. Finally, we emphasize how detailed knowledge of neutrophil functions in cardiovascular homeostasis and disease can be used to generate therapeutic strategies to target neutrophil numbers, functional status and effector mechanisms.
中性粒细胞传统上被视为心血管疾病的旁观者或生物标志物。然而,过去十年的研究表明,中性粒细胞在心血管炎症和修复过程中具有重要功能。在这篇综述中,我们讨论了传统和新型心血管危险因素对中性粒细胞产生和功能的影响。然后,我们评估了中性粒细胞对动脉粥样硬化不同阶段(包括动脉粥样硬化形成、斑块不稳定和斑块侵蚀)的贡献的现有知识。在动脉粥样硬化心血管并发症的背景下,我们强调了中性粒细胞在中风、心力衰竭、心肌梗死和新生内膜形成等致病和修复过程中的双重作用。最后,我们强调了详细了解中性粒细胞在心血管稳态和疾病中的功能如何用于产生靶向中性粒细胞数量、功能状态和效应机制的治疗策略。